The retinoblastoma protein C-terminal domain (RbC) is necessary for the tumor suppressor protein's activities in growth suppression and E2F transcription factor inhibition. Cyclin-dependent kinase phosphorylation of RbC contributes to Rb inactivation and weakens the Rb-E2F inhibitory complex. Here we demonstrate two mechanisms for how RbC phosphorylation inhibits E2F binding. We find that phosphorylation of S788 and S795 weakens the direct association between the N-terminal portion of RbC (RbC N ) and the marked-box domains of E2F and its heterodimerization partner DP. Phosphorylation of these sites and S807/S811 also induces an intramolecular association between RbC and the pocket domain, which overlaps with the site of E2F transactivation domain binding. A reduction in E2F binding affinity occurs with S788/S795 phosphorylation that is additive with the effects of phosphorylation at other sites, and we propose a structural mechanism that explains this additivity. We find that different Rb phosphorylation events have distinct effects on activating E2F family members, which suggests a novel mechanism for how Rb may differentially regulate E2F activities.
Introduction
The retinoblastoma protein (Rb) is a broad-functioning tumor suppressor that is frequently deregulated in human cancers [1, 2] . The loss of functional Rb is associated with several hallmarks of cancer including chromosomal instability and aberrant cell proliferation. Rb acts as a negative regulator of cell division at the G 1 -S transition of the cell cycle [3] [4] [5] [6] . In G 0 and early G 1 , Rb forms a growth-repressive complex with E2F transcription factors [7, 8] . The Rb-E2F complex is stabilized through two cohesive interactions ( Fig. 1a and b) : the pocket domain of Rb binds and represses the E2F transactivation domain (E2F TD ) [9] [10] [11] , and the C-terminal domain of Rb (RbC) associates with the E2F-DP marked-box and coiled-coil domains (E2F-DP CM ) [12] [13] [14] . These structured interactions are consistent with the finding that both the pocket domain and RbC are required for full growth suppression and E2F binding [15] [16] [17] .
Cyclin-dependent kinases (CDKs) phosphorylate Rb at specific CDK-consensus sites in late G 1 (Fig. 1 ) [3] [4] [5] [6] [18] [19] [20] [21] . Hyperphosphorylated Rb dissociates from E2F, allowing for up-regulation of E2F-mediated transcription and entry into S-phase [15, 22, 23] . Protein crystal structures have revealed how several key phosphorylation events induce conformational changes to Rb that disrupt the Rb-E2F interfaces (Fig. 1c) [24] . Phosphorylation of S608/S612 in the pocket loop (Rb PL ) promotes a binding interaction between Rb PL and the pocket domain that is structurally analogous to the Rb-E2F TD binding interaction [25, 26] . Phosphorylation of T373 in the interdomain linker (Rb IDL ) stabilizes binding between the pocket domain and the N-terminal domain (RbN), inducing an allosteric change to the E2F TD binding site in the pocket [26, 27] . Phosphorylation of T821 and T826 in RbC also induces an intramolecular association between RbC and the pocket at the "LxCxE" binding site [14, 28, 29] ; data suggest that this interaction dissociates proteins involved in chromatin remodeling and gene silencing [28] . Quantitative binding studies have revealed that phosphorylation of sites in RbC also reduces binding between RbC and E2F1-DP1 CM , although this inhibitory mechanism has not been clarified [14] .
RbC phosphorylation is a critical component of E2F activation and is necessary for full transactivation activity at E2F-bound promoters [30, 31] . Here we therefore sought to determine whether RbC phosphorylation destabilizes binding between Rb and the E2F transactivation domain. In this study, we use isothermal titration calorimetry (ITC) and nuclear magnetic resonance (NMR) to observe phosphorylation-dependent changes in binding between Rb and E2F. We find that phosphorylation of S788 and S795 in the N-terminal region of RbC (RbC N ) inhibits the Rb-E2F TD association by inducing binding of RbC N to the pocket domain. In addition, phosphorylation of RbC N abrogates the association between RbC N and the E2F1-DP1 CM complex. We find that phosphorylation of RbC N at S788/S795 is additive to the effects of Rb IDL and Rb PL phosphorylation in inhibiting Rb-E2F TD binding, indicating that structural compatibilities exist between these distinct mechanisms. Finally, we identify differences in how these phosphorylation-induced inhibitory mechanisms affect the binding of paralogous "activating" E2F TD s (E2F1-3) to Rb. Together, these binding studies contribute to a complete understanding of how specific post-translational phosphorylation events regulate the distinct functional interfaces of this critical cell cycle regulatory protein.
Results

RbC
N (S788/S795) phosphorylation inhibits E2F1 TD binding to Rb pocket by ITC
We used ITC to measure binding affinities of E2F1 TD (residues 372-437) for a series of Rb constructs, each engineered to contain specific RbC N phosphorylation sites (Table 1 and Supplementary  Fig. S1 ). The proteins were phosphorylated quantitatively with recombinant CDK as needed (Supplementary Fig. S2 ). We first tested binding of E2F1 TD to an Rb construct (Rb 380-816ΔPL/S780A ) that contains the pocket domain and four phosphoacceptor sites (S788/S795/S807/S811) but lacks the Rb PL sites (S608/S612) and S780. S780 phosphorylation does not influence E2F TD binding [25] , and the S780A mutation facilitates homogeneous phosphorylation in the preparative in vitro kinase reaction. We found that E2F1 TD binds to phosphorylated Rb Fig. 2a and b) . The broadening is protein concentration dependent (Fig. 2b) and anticipated for binding between the relatively small labeled peptide and the larger unlabeled pocket domain (molecular mass,~43 kDa). Binding between phosphorylated RbC 787-816 and the pocket domain is too weak to be detected in trans by ITC (data not shown); this weak binding (K d N~100 μM) is consistent with the high protein concentrations needed to observe the broadening effect in the NMR experiment. Peak broadening is not observed for the 15 N-labeled unphosphorylated peptide in the presence of excess Rb pocket, demonstrating that the RbC N -Rb pocket interaction is dependent on phosphorylation of the RbC N peptide ( Fig. 2c and Supplementary Fig. S3 ).
NMR peaks in the phosphorylated RbC 787-816 spectrum were assigned using standard methods. The peaks that undergo the most pronounced broadening correspond to clusters of residues surrounding phosphorylated S788, S795, and S807 (Fig. 2b) . The most straightforward interpretation of this result is that residues in these sequences directly contact the pocket domain. However, we cannot rule out the possibility that a subset of these spectral perturbations result from structural changes in RbC N that occur upon association. Peaks corresponding to residues surrounding S807 are influenced in the pocket titration, even though these residues do not contribute to inhibition of E2F1 TD in the ITC assay. The chemical environments of these residues are perhaps influenced by pocket binding in a manner that is independent of the effect of phosphorylated RbC on E2F inhibition. We next tested whether binding of phosphorylated RbC N and E2F TD to the pocket is mutually exclusive. We titrated a labeled, phosphorylated RbC N sample with unlabeled Rb pocket that is first saturated with 1 molar equivalent of E2F2
TD . In this case, we observe reduced peak broadening effects, demonstrating that E2F TD competes with phosphorylated RbC N in binding the pocket ( Fig. 2b and d) .
We examined the structure of the pocket-E2F2 TD complex to identify potential binding sites between the pocket and phosphorylated RbC N (Fig. 3a) . We found two clusters of conserved side chains that are capable of coordinating a phosphate. These side chains make interactions with E2F
TD that would likely be disrupted by RbC N binding and are in close proximity to the structured C-terminus of the pocket (I785 in the E2F2 TD -pocket structure) [10] . One site is near K652 ITC data are shown in Supplementary Fig. S1 .
and R656. K652 forms a salt bridge with E417 in E2F2. A second potential site is formed by K548, H555, R661, and H733. K548 and H555 hydrogen bond with D410 and D411 in E2F2 TD , respectively. We used the NMR assay to examine whether mutation of these sites influences the binding of phosRbC N to the pocket domain (Fig. 3b) . We added unlabeled wild type, K652A/R656A, and H555A/ H733A pocket to 15 N-labeled phosRbC 787-816 and compared the line-broadening in the spectra. The K652A/R656A pocket mutant shows reduced broadening consistent with loss of affinity, while the H555A/ H733A mutant shows similar behavior as wild type. These data indicate that phosRbC N binding requires an interaction with the conserved K652/R656 site in the pocket. . Ratios are plotted for addition of 300 μM (dark blue) and 900 μM (cyan) unlabeled Rb pocket 380-787ΔPL and for addition of 900 μM pocket in the presence of 900 μM unlabeled E2F2 TD (red). Intensity ratios were not quantified for overlapping peaks and prolines, marked with an asterisk (*). (c) HSQC spectra of 60 μM 15 N-labeled unphosphorylated RbC 787-816 alone (black) and in the presence of 900 μM unlabeled Rb pocket 380-787ΔPL (cyan). The absence of peak broadening indicates a lack of binding between unphosphorylated RbC 787-816 and Rb pocket, which demonstrates that binding between RbC 787-816 and the pocket is dependent upon phosphorylation. The ratio of peak intensities in the presence and absence of pocket domain are plotted in Supplementary Fig. S3. ( (Fig. 4a) . By comparing the spectra, we observe extensive signal-broadening indicative of complex formation between unphosphorylated RbC N and E2F1-DP1
CM . When we conduct this experiment using phosphorylated 15 N-labeled RbC N , we see less signal-broadening (Fig. 4b) , suggesting that phosphorylation of RbC N destabilizes the direct binding interaction with E2F-DP1 CM . Taken together with the NMR data demonstrating an RbC N -pocket interaction (Fig. 2) , these results suggest that RbC N phosphorylation has two distinct roles in disrupting the overall Rb-E2F complex (Fig. 4c) (Fig. 5a  and b) . This 45-fold reduction in E2F1 TD binding is nearly the product of the 10-fold and 7-fold effects observed independently, indicating that the Rb PL and RbC N mechanisms work together to inhibit the Rb-E2F1 TD complex. . As shown in the schematic diagrams, these constructs each contain elements needed for two inhibitory mechanisms. Their phosphorylation results in reduced affinity that is greater than constructs containing single inhibitory mechanisms. TD binds 230-fold more weakly when this Rb construct is phosphorylated (K d = 30 ± 10 μM) compared to when it is unphosphorylated (K d = 0.13 ± 0.05 μM) (Fig. 5c and d) . RbC N and Rb IDL phosphorylation mechanisms are therefore also additive, as phosphorylation at these sites has a 7-fold and 45-fold effect alone, respectively. These data indicate that RbC N phosphorylation functions in a manner that is functionally compatible with the mechanisms induced by phosphorylation of Rb IDL and Rb PL , lending insight into the way that these three separate structural mechanisms contribute to the inhibition of Rb-E2F TD binding.
Phosphorylation mechanisms regulate E2Fs differently
The E2F family of transcription factors consists of members that both activate transcription (E2F1-3) and repress transcription (E2F4-8). During G 0 and early G 1 , Rb negatively regulates transcription by binding and repressing activating E2F1-3, whereas the Rb paralogs p107 and p130 associate with repressive E2F4 and E2F5 [32] . E2F1-5 display a large degree of sequence and structural similarity, and crystal structures of E2F1 TD and E2F2 TD bound to Rb pocket reveal mostly similar binding modes. There are some notable, albeit subtle, differences in binding. For example, E2F2
TD makes additional salt bridge and hydrogen bond contacts through D410 and D411, which are not observed in the structure of Rb-E2F1 TD [10, 11] . These differences in binding contacts suggest that E2Fs may be differentially affected by the distinct phosphorylation-induced mechanisms for E2F release.
We compared binding of E2F1 TD , E2F2 TD , and E2F3 TD to Rb constructs designed to promote the specific phosphorylation-induced structural mechanisms we have identified for inhibiting E2F TD binding.
These ITC data are summarized in Table 2 and shown in Supplementary Fig. S4 . TD may only require any one phosphorylation event for micromolar affinity. Finally, we note that, in the context of full-length phosphorylated Rb, it was observed that deletion of RbC has no effect on the inhibition of E2F1 TD binding [25] . We suggest that the inhibitory effect of RbC N phosphorylation observed here may not be additive with both Rb IDL and Rb PL phosphorylation together. Another possible explanation is that the association between RbC and the pocket induced by T821/T826 phosphorylation negatively influences the ability of phosphorylated RbC N to bind the pocket and inhibit E2F TD . Further exploration of the interdependence of phosphorylation events and their corresponding structural changes is needed to address these possibilities. 
Discussion
Rb inactivation by multisite phosphorylation is required for cell cycle advancement into S-phase and is commonly found in tumors. The studies presented here reveal a novel phosphorylation-induced mechanism that utilizes RbC and contributes to inhibition of the Rb-E2F growth-repressive complex. Our data demonstrate that S788/S795 phosphorylation plays a dual role in disrupting both the RbC-E2F1-DP1 CM (Fig. 3 ) [26] . Alternatively, Rb PL phosphorylation targets a separate Rb-E2F TD interface near the C-terminus of E2F TD [26] . We propose that the additive effect of RbC N and Rb PL phosphorylation in inhibiting Rb-E2F TD binding occurs because these two mechanisms each targets a distinct, stabilizing subsection of the overall Rb-E2F TD interface. We find that S807/S811 phosphorylation does not contribute to inhibition of the Rb-E2F TD interaction either alone or in the presence of S788/S795. Although it remains a formal possibility that these residues contribute in some unique way to the regulation of Rb-E2F, other roles for these phosphoacceptor sites have been suggested, including modulating interactions with other proteins and serving as priming sites for subsequent phosphorylation events [24, 29, 33] .
The quantitative binding studies presented here are consistent with cell-based studies, which indicate that S788/S795 phosphorylation plays a role in the dissociation of Rb-E2F complexes and E2F transactivation that is additive with other sites. Transcriptional assays using alanine substitutions at S788 and S795 show that these mutations alone are not sufficient to suppress E2F activation in the presence of kinase [30] . However, these mutations do greatly enhance the effects of additional phosphoacceptor mutations in suppressing E2F activity in the presence of kinase. A similar study confirms that S795 phosphorylation alone is insufficient to induce E2F activity [34] . In cells, S795 phosphorylation is most likely the target of CDK4, and not CDK2 [21, 35, 36] . More recent studies have shown that S795 phosphorylation and E2F activation also occur in response to p38 activation [37, 38] .
We tested for the first time here the specific effects of each phosphorylation mechanism on different activating E2F transactivation domains. We found that, while discrete phosphorylation at T356/T373, S608/S612, or S788/S795 reduces the affinity of Rb for E2F1 TD TD is noteworthy considering that activating E2Fs have distinct cellular functions, regulate only partially overlapping sets of genes, and show differences in how they regulate expression in conjunction with other transcription factors and post-translational modifications [32, 39, 40] . We suggest that such differential effects of phosphorylation provide a possible mechanism for tuning different E2F family member activities separately. Further identification of specific Rb phosphorylation events in different cellular contexts remains an important goal for understanding when and how these mechanisms contribute to Rb regulation of E2F activity.
Materials and Methods
Protein expression, purification, and phosphorylation Rb and E2F protein constructs were expressed in Escherichia coli as fusion proteins with glutathione S-transferase (GST). Cells were induced overnight at room temperature with the exception of RbC 787-816 , which was induced for 2.5 h at 37°C. Cells were re-suspended in a lysate buffer containing 100 mM NaCl, 25 mM TrisHCl (pH 8.0), 1 mM PMSF, and 1 mM dithiothreitol; passed twice through a cell homogenizer; and centrifuged at 27,000g for 30 min. The supernatant fraction of the lysate was loaded to GS4B affinity resin and eluted with 10 mM glutathione. Eluate was further purified using anion-exchange chromatography. The GST tag was cleaved overnight at 4°C with 1% (percentage mass of substrate in the reaction) GST-tagged tobacco etch virus, and the cleaved protein was passed back over GS4B resin to remove GST. E2F1-DP1
CM was prepared and purified as described previously [14] .
Purified Rb protein was phosphorylated by concentrating to 4 mg/mL and incubating in a reaction containing 5% CDK2-CyclinA, 10 mM ATP, 10 mM MgCl 2 , 100 mM NaCl, 25 mM Tris-HCl (pH 8.0), and 1 mM dithiothreitol at 4°C overnight. Quantitative phosphorylation of RbC 787-816 could be achieved but required using 5% CDK2-CyclinA and 2% CDK6-CyclinK. Proteins were analyzed for phosphate incorporation using electrospray ionization mass spectrometry as previously described [25] . A sample mass spectrometry experiment demonstrating quantitative phosphorylation is shown in Supplementary Fig. S2 .
NMR spectroscopy
All samples were prepared in a buffer containing 50 mM NaPO 4 , 5 mM dithiothreitol, and 10% D 2 O (pH 6.1). N total correlated spectroscopy spectrum (120 ms mixing time) and a threedimensional 1 N-15 N nuclear Overhauser enhancement spectroscopy spectrum (360 ms mixing time) [41, 42] . All NMR spectra were processed with NMRPipe and analyzed with NMRViewJ [43, 44] .
Isothermal titration calorimetry
ITC experiments were conducted with a MicroCal VP-ITC calorimeter. Proteins were dialyzed overnight in a buffer containing 100 mM NaCl, 25 mM Tris-HCl (pH 8.0), and 1 mM dithiothreitol. The data were fit to one-site binding using the Origin software package. Reported error values reflect the standard deviation of 2-4 separate binding experiments. In all cases, the stoichiometry parameter was determined to be around n~1.
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